Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Tackling the mental health crisis plaguing the veterinary profession
    • Opinion

    Tackling the mental health crisis plaguing the veterinary profession

    The veterinary profession is in a state of flux. Whilst highly rewarding, the high-pressure demands of the job are testing, and often associated with a high risk of poor mental health. With increased society wide focus on mental health and wellbeing in recent years, awareness of what vets go through behind closed doors is onRead More
    Public
  • BikeExchange to offer fully-built bikes delivered from online sales via Kitzuma acquisition
    • News

    BikeExchange to offer fully-built bikes delivered from online sales via Kitzuma acquisition

    Online bicycle marketplace operator BikeExchange (ASX: BEX) is addressing one of the biggest pain points to buying a bike online, by offering them fully built without the need to put it together from a box via their acquisition of delivery and logistics company Kitzuma. As a growing business that services all major regions of North

    Read More
    Public
  • Creating a culture of wellbeing to become an employer of choice
    • News

    Creating a culture of wellbeing to become an employer of choice

    Whilst they might have just been acquired by fintech giant HUB24 (ASX: HUB) things haven’t changed at Class (ASX: CL1) with regard to their people and culture.  Investing in people has always been a priority for the tech company, especially given the so called ‘war on talent’ that has hiring managers and HR staff pulling

    Read More
    Public
  • Special delivery: unique drug delivery system receives new US patent
    • News

    Special delivery: unique drug delivery system receives new US patent

    Let’s rewind to Year 10 biology- you know that mitochondria is the powerhouse of the cell, chances are you vaguely remember the golgi apparatus but do you remember what an exosome is? Exosomes, or extracellular vesicles are little packages delivering molecules and enhancing cell-to-cell communication. Clinical- stage biopharmaceutical company Exopharm (ASX: EX1) is utilising exosomes

    Read More
    Public
  • Marley Spoon emerges as winner of meal delivery stakes with acquisition of Chefgood
    • News

    Marley Spoon emerges as winner of meal delivery stakes with acquisition of Chefgood

    Having ridden out the surge in demand for meal delivery services brought upon by the pandemic, Marley Spoon (ASX: MMM) is set to be one of the few brands that will maintain that momentum in the post-COVID world with the sector poised to undergo a period of consolidation.  Demand for such services was first accelerated

    Read More
    Public
  • Nine fights back against streaming services, extends NRL broadcast deal by 5 years for $650m
    • News

    Nine fights back against streaming services, extends NRL broadcast deal by 5 years for $650m

    If there’s one thing the NRL can do that the AFL cannot, it is maintain just one partner – in broadcasting terms at least. The 30 year marriage will continue at least to the end of 2027 with the National Rugby League (NRL) agreeing to terms with Nine Entertainment (ASX: NEC) for a 5-year extension

    Read More
    Public
  • «
  • ‹
  • 426
  • 427
  • 428
  • 429
  • 430
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.